Hutch News
Results per Page:
Machine learning identifies biomarkers that predict a patient’s response to immunotherapy
From the Gujral Lab, Human Biology Division
Drug identified to combat Omicron-induced cytokine storm
From the Gujral Lab, Human Biology Division
Development of an in vitro model system to study tricky-to-target tumor microenvironment cells
From the Gujral Lab, Human Biology Division
Computational predictions reveal an unexpected synergy for prostate cancer therapy
From the Gujral Lab, Human Biology Division
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
New strategy to weather the (cytokine) storm
From the Gujral Lab, Human Biology Division
Liver cancer researcher Dr. Abir Arfaoui named latest Brave Fellow
Running community honors late athlete Gabe Grunewald by funding rare cancer research at Fred Hutch
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Tip Sheet: New COVID-19 transmission study, returning to school, video of biorepositories — and a new weight loss study
Summaries of recent Fred Hutch research findings and other news
Outlining the molecular networks that alter cell function and behavior
Dr. Taran Gujral’s NSF CAREER Award will allow him to study how cells shift to new functional states in normal development and disease
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Shifting liver cancer cells away from migratory state could reduce their drug resistance
Researchers hope lab-based study helps build foundation for personalized treatment of hepatocellular carcinoma
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
Good News: Fred Hutch immunotherapy expert Dr. Phil Greenberg joins Parker Institute
Celebrating faculty and staff achievements
Good News: Dr. Sue Biggins named a 2017 ASCB fellow
Celebrating faculty and staff achievements
In crowded spaces Hippo hinders chemo
From Taran Gujral, Human Biology Division
Good News: 8 Fred Hutch/UW researchers receive pilot awards
Celebrating faculty and staff achievements
Good News: First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy
Celebrating faculty and staff achievements